CX3CL1 and myocardial infarction: We hypothesise this is due to increased CX3CR1/fractalkine interaction, as in vitro incubation of PBMCs with fractalkine reduces CX3CR1 fluorescence and, in vivo, MI patients with increased fractalkine concentration after reperfusion display reduced CX3CR1 receptor expression.